Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia

Details for Australian Patent Application No. 2006231759 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Hirai, Keisuke; Miyamoto, Masaomi

Agent Griffith Hack

Pub. Number AU-A-2006231759

PCT Pub. Number WO2006/107027

Priority 2005-107673 04.04.05 JP

Filing date 3 April 2006

Wipo publication date 12 October 2006

International Classifications

C07D 307/77 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/107027 Priority application(s): WO2006/107027

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006231784-Anti-CD-20 monoclonal antibody

2006231752-Preventive or remedy for depression or anxiety neurosis